Thymidine analog choice determines how newly synthesized DNA is detected. BrdU is measured through antibody-based detection, whereas EdU is detected using click chemistry, a chemical labeling reaction. In either case, incorporation marks DNA made during the labeling period, allowing investigators to identify cells actively progressing through synthesis and compare replication activity across experimental conditions.
DNA-content analysis provides a cell-cycle framework for interpreting labeling results. Flow cytometry can separate cells with DNA amounts associated with G1, S, and G2/M populations, while BrdU or EdU identifies newly synthesized DNA. Combining these measurements helps place replication activity within overall cell-cycle progression rather than evaluating DNA synthesis in isolation.
Cell-cycle arrest can be evaluated by examining how an experimental treatment changes the fraction of cells incorporating a thymidine analog and their distribution among DNA-content populations. A treatment that alters these measurements may affect progression through synthesis or other cell-cycle stages. This makes the approach useful for studying how drugs or genetic changes modify proliferation.
A typical workflow labels cells with a thymidine analog so that newly synthesized DNA contains BrdU or EdU. The incorporated label is then detected with an antibody-based assay or click chemistry, respectively. Researchers may pair this measurement with DNA-content analysis by flow cytometry to distinguish replication activity from the G1 and G2/M populations.
Researchers use this measurement when they need to evaluate cell proliferation or cell-cycle progression in biological systems. It supports studies of development and cancer, where changes in DNA replication can reflect altered growth behavior. The same strategy also helps examine replication dynamics and responses to experimental drugs or genetic changes.
The assay can show whether a treatment or genetic change is associated with altered DNA replication, proliferation, or cell-cycle progression. When combined with DNA-content measurements, it can also indicate how cells are distributed across G1, S, and G2/M. These outcomes help investigators assess cell-cycle arrest and examine responses linked to DNA damage.